Company profile for Dong-A ST Co., Ltd.

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Dong-A ST(formerly Dong-A Pharm)has continually worked to become a pharmaceutical company that specializes in innovative new drugs. Dong-A ST is establishing a presence in the world markets based on its own pipeline, which has produced such high-profile ethical drugs as Zydena (Udenafil) for erectile dysfunction, Stillen (Eupatilin) for gastritis and Motilitone (Corydaline) for functional dyspepsia. Dong-A ST is also producing...
Dong-A ST(formerly Dong-A Pharm)has continually worked to become a pharmaceutical company that specializes in innovative new drugs. Dong-A ST is establishing a presence in the world markets based on its own pipeline, which has produced such high-profile ethical drugs as Zydena (Udenafil) for erectile dysfunction, Stillen (Eupatilin) for gastritis and Motilitone (Corydaline) for functional dyspepsia. Dong-A ST is also producing a wide range of qualified APIs (Cycloserine, Terizidone, Eprirubicin, Imatinib, Pemetrexed, Entecavir etc.) and Biological products (Follitropin, Somatropin, Filgrastim, Erythropoietin). Dong-A ST has significant experience in animal cell culture, long-acting protein technology, gene therapy, monocolonal antibody therapeutics and biopharmaceutical screening

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
64 Cheonhodaero Dongdaemun-gu, Seoul 130-823
Telephone
Telephone
+82 02 920 8114
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/xtalpi-signs-mou-with-dong-a-st-for-joint-research-and-development-of-immunology-and-inflammation-therapies-302534023.html

PR NEWSWIRE
19 Aug 2025

https://www.businesswire.com/news/home/20241219254328/en

BUSINESSWIRE
19 Dec 2024

https://www.businesswire.com/news/home/20240610088981/en

BUSINESSWIRE
10 Jun 2024

https://www.businesswire.com/news/home/20221109005472/en

BUSINESSWIRE
09 Nov 2022

https://www.prnewswire.com/news-releases/dong-a-st-and-beactica-therapeutics-mutually-agree-to-conclude-oncology-collaboration-301618002.html

PRNEWSWIRE
06 Sep 2022

https://www.biospectrumasia.com/news/25/15019/dong-a-st-with-beactica-to-develop-new-cancer-treatments.html

BIOSPECTRUM ASIA
03 Dec 2019

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Dong-A ST Co., Ltd. and get a quotation

Dong-A ST Co., Ltd. is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Atorvastatin bulk with JDMF offered by Dong-A ST Co., Ltd.

Find a price of Epirubicin Hydrochloride bulk offered by Dong-A ST Co., Ltd.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty